INGN Inogen Inc
- Stocks
- Healthcare
- NASDAQ: INGN
Price (delayed)
$7.46
Market cap
$201.72M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.06
Enterprise value
$115.8M
Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental
Highlights
Inogen's EPS has soared by 73% YoY and by 8% from the previous quarter
Inogen's net income has soared by 72% YoY and by 5% from the previous quarter
Key stats
What are the main financial stats of INGN
Market
Valuations
Earnings
Shares outstanding
27.04M
Market cap
$201.72M
Enterprise value
$115.8M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.01
Price to sales (P/S)
0.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.34
Revenue
$343.47M
Gross profit
$155.35M
Operating income
-$32.96M
Net income
-$26.05M
EBIT
-$26.73M
EBITDA
-$5.93M
Free cash flow
-$22.37M
Per share
Balance sheet
Liquidity
EPS
-$1.06
EPS diluted
-$1.06
Free cash flow per share
-$0.83
Book value per share
$7.42
Revenue per share
$12.74
TBVPS
$9.94
Total assets
$312.04M
Total liabilities
$112.55M
Debt
$19.04M
Equity
$199.49M
Working capital
$136.05M
Debt to equity
0.1
Current ratio
3.03
Quick ratio
2.42
Net debt/EBITDA
14.49
Margins
Efficiency
Dividend
EBITDA margin
-1.7%
Gross margin
45.2%
Net margin
-7.6%
Operating margin
-9.6%
Return on assets
-8.5%
Return on equity
-13.8%
Return on invested capital
-27%
Return on capital employed
-10.9%
Return on sales
-7.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INGN stock price
How has the Inogen stock price performed over time
Intraday
-2.74%
1 week
15.12%
1 month
13.89%
1 year
-40.84%
YTD
-18.65%
QTD
6.12%
Financial performance
How have Inogen's revenue and profit performed over time
Revenue
$343.47M
Gross profit
$155.35M
Operating income
-$32.96M
Net income
-$26.05M
Gross margin
45.2%
Net margin
-7.6%
The net margin has soared by 73% year-on-year and by 6% since the previous quarter
Inogen's net income has soared by 72% YoY and by 5% from the previous quarter
The operating margin has soared by 68% YoY and by 4% from the previous quarter
INGN's operating income has surged by 67% year-on-year and by 2.8% since the previous quarter
Price vs fundamentals
How does INGN's price correlate with its fundamentals
Growth
What is Inogen's growth rate over time
Valuation
What is Inogen stock price valuation
P/E
N/A
P/B
1.01
P/S
0.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.34
Inogen's EPS has soared by 73% YoY and by 8% from the previous quarter
INGN's P/B is 37% below its 5-year quarterly average of 1.6 and 8% below its last 4 quarters average of 1.1
The equity rose by 6% year-on-year
The stock's price to sales (P/S) is 61% less than its 5-year quarterly average of 1.5
The revenue has increased by 5% year-on-year
Efficiency
How efficient is Inogen business performance
Inogen's ROS has soared by 73% YoY and by 4.9% from the previous quarter
Inogen's ROA has soared by 70% YoY and by 6% from the previous quarter
Inogen's return on equity has surged by 70% YoY and by 7% QoQ
INGN's ROIC has soared by 66% YoY and by 5% from the previous quarter
Dividends
What is INGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INGN.
Financial health
How did Inogen financials performed over time
INGN's total assets is 177% greater than its total liabilities
The company's current ratio rose by 12% YoY
The quick ratio has grown by 11% YoY
The debt is 90% smaller than the equity
The debt has declined by 11% year-on-year
The debt to equity has decreased by 9% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.